Lisdexamfetamine, marketed as Vyvanse, is a prescription medication indicated for attention deficit hyperactivity disorder in children and individuals. In Canada, its access is managed by Health Canada. This https://apo-lisdexamfetamine-for301302.bloggerpal.com/555659/lisdexamfetamine-in-canada-a-complete-guide